Equillium, Inc.
Equillium, Inc., a clinical-stage biotechnology company, develops and sells products to treat severe autoimmune and inflammatory, or immuno-inflammatory disorders with unmet medical need. The company's lead product candidate is itolizumab (EQ001), a clin…
Biotechnology
US, La Jolla [HQ]
Lobbying Analysis
Lobbying · US Senate · Influence
Equillium, Inc. has no lobbying expenses in our database.
History
DownloadFY | Quarter | Expense For Lobby Disclosure | LDA Reference |
---|---|---|---|
No data |